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Abstract.  The yeast nuclear envelope protein NSP1 is 
located at the nuclear pores and mediates its essential 
function via the carboxy-terminal domain.  The pas- 
senger protein,  cytosolic dihydrofolate reductase from 
mouse, was fused to the 220 residue long NSP1 
carboxy-terminal domain.  When expressed in yeast, 
this chimeric protein was tightly associated with nu- 
clear structures and was localized at the nuclear pe- 
riphery very similar to authentic NSP1.  Furthermore, 
the DHFR-C-NSP1 fusion protein was able to comple- 
ment a yeast mutant lacking a  functional NSP1 gene 
showing that DHFR-C-NSP1 fulfils the same basic 
function as compared to the endogenous NSP1 pro- 
tein.  These data also show that the NSP1 protein is 
composed of separate functional moieties: a carboxy- 
terminal domain that is sufficient to mediate the as- 
sociation with the nuclear periphery and an amino- 
terminal  and middle repetitive domain with an as yet 
unknown function.  It is suggested that heptad repeats 
found in the NSP1 carboxy-terminal domain,  which 
are similar to those found in intermediate filament 
proteins,  are crucial  for mediating the association with 
the nuclear pores. 
T 
HE nuclear pores are the sites of transport of proteins 
and nucleic acids between the nuclear and cytoplasmic 
compartments  (for  review,  Dingwall  and  Laskey, 
1986; Gerace and Burke,  1988). The transport through  the 
pores is mediated by specific nuclear targeting  signals  that 
are found in many nuclear proteins and recognized by recep- 
tors presumably located at the nuclear periphery and the nu- 
clear pores (Kalderon et al.,  1984; Newmeyer and Forbes, 
1988; for review see also, Gerace and Burke,  1988). Nuclear 
pores are composed of supramolecular complexes,  the nu- 
clear pore complexes,  which reveal an octagonal symmetry 
in the electron microscope and have an estimated molecular 
mass of approximately 100  x  10  ~ D (Unwin and Milligan, 
1982; Reichelt et al., 1990). Several components of the nu- 
clear pores have been identified and a role in nuclear trans- 
port has been proposed for a few of them (Gerace et al., 
1982; Davis and Blobel, 1986, 1987; Park et al., 1987; Snow 
et al.,  1987). Recently, cDNA probes for nuclear pore pro- 
teins were cloned and the DNA sequence and the deduced 
amino acid sequence of nuclear pore proteins is now avail- 
able (D'Onofrio et al.,  1988; Wozniak et al.,  1989; Starr et 
al.,  1990).  Nuclear pore proteins  have been identified  in 
yeast (Ads and Blobel, 1989; Nehrbass et al.,  1990; Davis 
and Fink,  1990) and an essential  role in nuclear envelope 
functions has been implied (Nehrbass et al.,  1990). By im- 
munological cross-reactivity,  it has been shown that the yeast 
nuclear pore proteins NSP1  and NUP1  are evolutionarily 
related to the mammalian nucleoporins of which p62 is the 
most prominent member (Davis and Blobel, 1986). 
So far, nothing is known aboUt how nuclear pore proteins 
reach their final destination.  This information,  however, is 
crucial to understand  the assembly of nuclear pore com- 
plexes and to piece together the mechanism by which nuclear 
proteins are targeted to the nuclear pores and imported into 
the nucleus. To address this problem, we analyzed the differ- 
ent domains of NSP1, a yeast nuclear pore protein, for their 
role in nuclear targeting  and nuclear pore association. 
Here,  we  demonstrate  that  the  220  amino  acid  long 
carboxy-terminal  domain of NSP1 contains signals to guide 
a murine cytosolic protein, dihydrofolate  reductase, to the 
nuclear periphery,  most likely to the nuclear pores. This is 
the  first  demonstration  of a  sequence mediating  nuclear 
envelope  association. 
Materials and Methods 
Yeast Strains and Media 
The  diploid  yeast  strain  JU4.2  x  JR26-19B  (a/c~,  ade2-1/ade2-1, 
ade8/ADE8, cardA00/canl-100, his4/HIS4, his3/HIS3, leu2-3/leu2-3, lysl- 
1/lysl-1,  ura3-52/ura3-52)  and  TF2  heterozygous  for  NSPI  (a/c~, ade2- 
1/ade2-1,  adeS/ADE8,  canl-100/card-100,  his4/HIS4,  his3/HIS3,  leu2- 
3/!eu2-3,  lysl-1/lysl-1,  ura3/nspl::URA3/NSP1)  have  been  used  (Hurt, 
1988). Strains were grown in rich YPD (yeast extract, peptone, D-glucose) 
medium or minimal medium containing glucose or galactose as described 
in Hurt,  1988. 
Construction of a Haploid Yeast Strain Expressing a 
Fusion Protein Between Dihydrofolate Reductase from 
Mo~e and the NSP1 Carboxy-Terminal Domain 
DNA recombinant work was performed according to published procedures 
(Maniatis et al.,  1982). The DNA coding for the COOH-terminal domain 
of NSP1 was isolated by restriction as described (Nehrbass et al., 1990) and 
its Y-end was fused in frame to the Y-end of the mouse DHFR gene whose 
stop codon has been altered by  introduction of a  Bgl H  restriction site 
(Hochuli et al., 1988). This fusion gene, which encoded a chimeric protein 
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Figure  1.  Construction  of a  fusion protein  consisting  of the cy- 
tosolic  protein  dihydrofolate  reductase  and  the  NSP1  carboxy- 
terminal domain.  Schematic representation of the authentic NSP1 
protein,  the NSP1  carboxy-terminal domain alone (C-NSP1),  the 
fusion  protein  between  eytosolic  dihydrofolate  reduetase  from 
mouse and  the NSP1  carboxy-terminal domain  (DHFR-C-NSPI) 
and  authentic  dihydrofolate reductase  (DHFR).  Details for con- 
struction of the chimeric gene DHFR-C-NSP1, and its expression 
in yeast are outlined under Materials  and Methods.  Amino acid 
numbers are indicated below the schematic drawings. 
consisting of the entire dthydrofolate reductase coding sequence (residues 
1-187),  linker  amino  acids  (G-W-K-I-R-G-S) and  the carboxy-terminai 
NSPl-domain (from residues 606-823; see also Nehrbass et al., 1990) was 
placed under the control of the alcohol dehydrogenase (ADH) t I promoter 
(Hurt et al., 1985). The hybrid gone was inserted into a 2t~ plasmid CYEP13; 
Sherman et aL, 1986) carrying the LEU2 gene as a selectable marker. The 
derived recombinant plasmid is named YEPI3-ADHI-DHFR-C-NSP1.  The 
1. Abbrevian'on  used in this paper:  ADH, alcohol dehydrogenase. 
diploid strain TF2 heterozygous for NSP1 was transformed with this plasmid 
and LEU+-transformants were selected (Itoh et al.,  1983). 
Transformants were sporulated and tetrads dissected. All four spores of 
such tetrads were viable and no significant growth difference between tetrad 
spores  was evident.  URA+/LEU  + haploid progeny contained a disrupted 
NSP1  gene and expressed only the fusion protein of mouse dihydrofolate 
reductase linked to the COOH-terminal domain of NSP1 under the constitu- 
tively active ADH I promoter  as shown by immunoblotting. 
To express authentic DHFR in yeast, the gene for mouse DHFR was in- 
serted into plasmid pLGSD5 (Guarente et ai., 1982) under the control of 
the GALl0 promoter  (Hurt et at.,  1985) and transformed  into the strain 
JU4.2 x JR26-19B. Expression of  DHFR was induced by growing the cells 
in medium containing gaiactose  (Guarente et at.,  1982). 
Immune Sera, Affinity Purification of 
Antibodies,  Indirect Immunofluorescence, and 
Immunoelectron Microscopy 
Immune sera raised against Escherichia coil expressed NSPI (serum EC7-3 
and  EC9-3;  see also  Hurt,  1988) and  mouse  dihydrofolate  reductase 
(UM15-3; kindly provided by Dr. G. Schatz, Basel, Switzerland) were used. 
Immune serum EC7-3 contained mainly antibodies against NSP1; immune 
serum EC9-3 also contained antibodies cross-reactive with NSP2. Antibod- 
ies against NSPl were affinity purified as described earlier (Nehrbass et al., 
1990).  Antibodies  against  DHFR were  affinity purified  using  purified 
mouse DHFR (Sigma Chemical GmbH, Munich, Federal Republic of Ger- 
many), which was immobilized by blotting onto nitrocellulose. For indirect 
immunofluorescence, affinity-purified antibodies from five consecutive ela- 
tions were concentrated to ",,50 ~tl by ultrafiltration. 
Indirect immunoltuorescence on yeast cells (Nehrbass et al., 1990) and 
isolated nuclei (Hurt et al., 1988) was performed as described earlier;  in 
particular, yeast cells were fixed in 3 % formaldehyde before spheroplasting 
and nuclei were als0 fixed in 3 % formaldehyde before the latter were cen- 
trifuged on polylysine-coated coverslips. For indirect immunofluorescence, 
affinity-purified anti-NSFl and anti-DHFR antibodies in a 1:5 dilution were 
used followed by a second antibody, Texas red-labeled goat anti-rabbit  IgG, 
in a 1:100 dilution. For DNA staining, 0.5/~g/ml Hoechst 33258 was used. 
Labeled cells were inspected in a Zeiss Axiophot fluorescence microscope 
using the Plan-Neofluar  100x/1.3  objective and pictures were taken with 
Figure  2.  Expression  of the 
DHFR-C-NSP1 fusion protein 
in yeast.  Expression in yeast 
and E.  coli, of the fusion pro- 
tein corrg~osed  of  mouse DHFR 
and the carboxy-terminal do- 
main of NSP1 was carried out 
as described in Materials and 
Methods.  Yeast  cells  were 
grown  in  minimal  glucose 
medium  supplemented  with 
the appropriate  nutrients  and 
total protein extract was pre- 
pared.  Aliquots  of the  yeast 
and E. coli extracts were sepa- 
rated  on  a  SDS-12%  poly- 
acrylamide  gel  followed  by 
immunoblotting using affinity- 
purified  antibodies  against 
mouse DHFR (leO) and the immune serum EC9-3 made against NSP1  (right).  Lane 1, purified mouse DHFR (1  ~g; Sigma Chemical 
GmbH); lane 2, yeast control strain (TF2); lane 3, yeast strain expressing the DHFR-C-NSP1 fusion protein (TF2 transformed with plasmid 
YEP13-ADHI-DHFR-C-NSP1); lane 4, extract from E. coli expressing the DHFR-C-NSP1 fusion protein under a bacteriophage promoter. 
The positions of mouse DHFR, the DHFR-C-NSP1 fusion protein,  NSP1, and NSP2 are indicated by arrows.  The molecular masses of 
a protein standard are also shown. Note that the immune serum EC9-3 made against NSP1 cross-reacts with an immunologically related 
protein NSP2 (Nehrbass et ai.,  1990),  which is very prominent in the extract of TF2 transformed with plasmid YEP13-ADHI-DHFR-C- 
NSPI. We observed that the amount of immunodetectable NSP2 can vary in a  strain-dependent way. 
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nspl- yeast mutant by the fusion pro- 
tein  between  mouse  DHFR  and  the 
NSPI carboxy-terminal  domain. (A) Tet- 
tad analysis (top) and growth of a tetrad 
on YPD and selective plates (bottom). 
(Tbp) Yeast TF2 heterozygous for NSP1 
was tran.qformed with plasmid YEPI3- 
ADHI-DHFR-C-NSP1  and  the  corre- 
spo~llng diploid strain was sporulated 
and tetrads were analyzed. Tetrad prog- 
eny were grown for 3 d on YPD plates 
at 30°C. Four viable tetrad spores were 
generally recovered,  all  of which  ex- 
hibited similar growth rates. A  scheme 
for  the  meiotic segregation of the  in- 
tact and disrupted NSPI  gene and the 
plasmid YEPI3-ADHI-DI-IFR-C-NSP1 is 
also shown. (Bottom)  Two out of  the four 
viable haploid progeny (called BI-B4) 
grown on YPD (left plate) were always 
URA+/LEU  + (right SD [-ura-leu]  plate) 
indicating  that  they  carried  the  dis- 
rupted  nspl  gene  (disrupted  by  the 
URA3 gene) and plasmid YEPI3-ADHI- 
DI-IFR-C-NSPl  (containing the  LEU2 
gene).  Tetrad  C  only gave two  viable 
spores  which  were  ura-.  Most  likely 
this tetrad had lost the complementing 
plasmid  YEPI  3-ADHI-DHFR-C-NSP1 
during growth on the sporulation plate 
(YPA plate).  (B) Immunoblot analysis. 
Protein extracts  derived  from  a  com- 
plete tetrad  from strain TF2 heterozy- 
gous  for  NSPI  and  transformed  with 
plasmid  YEP13-ADHI-DHFR-C-NSP1 
were analyzed by SDS-12% polyacryl- 
amide gel electrophoresis and immuno- 
blotting using anti-NSPl antibodies. Im- 
mune  serum  EC7-3  was  used,  which 
reacts only with NSPI and the DHFR-C- 
NSP1 fusion protein, but not with NSP2. 
Lane 1, diploid yeast strain expressing 
the DHFR-C-NSP1 fusion protein (TF2 
transformed with plasmid YEP13-ADHI- 
DHFR-C-NSPI);  lanes  2-5,  haploid 
progeny from a tetrad derived from TF2 
transformed with plasmid YEPI3-ADHI- 
DHFR-C-NSP1; lanes 2  and 3, haploid 
progeny expressing only the DHFR-C- 
NSP1  fusion  protein  (URA+/LEU+); 
lanes 4 and 5, haploid progeny express- 
ing  only  authentic  NSP1  (ura-/leu-); 
plasmid  YEP13-ADHI-DHFR-C-NSP1 
was segregated out from these two hap- 
loid  progeny;  lane  6,  protein  extract 
from E. coli expressing the DHFR-C-NSP1 fusion protein under a bacteriophage promoter.  The position of the DHFR-C-NSP1 fusion 
protein and NSPI  is indicated by arrows.  The molecular masses of a protein standard are also given. 
TMY 400 film. Immunoelectron microscopy using aliinity-puritied anti- 
DHFR antibodies was subsequently performed (Griffiths  et al., 1984; Nehr- 
bass et al., 1990). 
Extraction of  Proteins  from Yeast Cells, SubceUular 
and Subnuclear Fractionation and lmmunoblotting 
Total protein extracts from yeast were prepared by resuspending freshly har- 
vested cells from a 50~ml  culture (OD 600 nm of 1) in 1.5 ml hot SDS sam- 
ple buffer. The sample was vortexed together with 400 micron glass beads 
followed by a 20-rain incubation at 96°C with occasional vortexing. The 
centrifuged extract corresponding to  10D  (600  nm) was applied on a 
SDS-polyacrylamide gel and separated proteins were blotted onto nitrocel- 
lulose. Filters were blocked by 2 % nonfat milk powder in PBS and immune 
sera were used in a 1:500 dilution. The protein bands were detected using 
protein A coupled to horseradish peroxidase. 
Spheroplasting of yeast cells  and subcellular  fractionation including 
purification of nuclei was done as described earlier (Hurt et al., 1988). 
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fusion protein in a haploid yeast nspl- strain and indirect immunofluorescence microscopy are described in Materials and Methods. (A) 
Indirect immunofluorescence  microscopy using affinity-purified  anti-DHFR antibodies on haploid yeasts with disrupted nspl and expressing 
the DHFR-C-NSPI fusion protein (top). Cells were also stained for DNA with Hoeehst 33258 (bottom). The immunofluorescence staining 
was punctate and patchy at the nuclear periphery, typical for nuclear pore labeling and highly similar to NSP1 immunolabeling (see also, 
Nehrbass et al., 1990). (B) Indirect immunofluoreseence microscopy on yeast expressing authentic dihydrofolate reduetase from mouse. 
Immunolabeling using anti-DHFR antibodies (top) and DNA-staining (bottom) is shown. (C) Indirect immunofluorescence microscopy 
on purified nuclei isolated from yeast expressing the DHFR-C-NSP1 fusion protein and authentic dihydrofolate reduetase (DHFR) from 
mouse. Immunolabeling using anti-DHFR antibodies and DNA staining is shown. 
Differential extraction of purified yeast nuclei with DNAse/RNAse, Triton 
X-100,  and 500 mM NaC1 was essentially as described (Aris and Blobei, 
1989).  Aliquots of the different subcellular fractions (onefold cell aliquot 
of  the homogenate and postnuclear supernatant; a 10-fold cell aliquot of  the 
crude nuclear pellet and the sucrose gradient fractions), as well as equal 
equivalents of the subnuclear fractions, were analyzed by SDS-PAGE and 
immunoblotting as described above. 
Results 
In Vivo Expression of the Fusion Protein 
Between Dihydrofolate Reductase and the NSP1 
Carboxy-Terminal Domain (DHFR-C-NSP1) 
in Yeast 
The carboxy-terminal domain of  NSP1 contains all the infor- 
mation to complement a yeast mutant lacking a functional 
nspl gene (Nehrbass et al.,  1990). Since antibodies against 
this  domain  did not stain  the yeast cells by  indirect im- 
munofluorescence, we could not determine its exact location 
within the nuclear compartment. We therefore  decided to tag 
this domain with a new epitope and attached to its amino ter- 
minus a reporter protein, cytosolic dihydrofolate reductase 
from mouse. We then analyzed whether the fusion protein 
can be targeted to the nuclear periphery.  The behavioral 
properties of the dihydrofolate reductase protein make it an 
excellent marker for the study of intracellular organelle tar- 
geting (Hurt et al.,  1984). If expressed in yeast, DHFR ex- 
clusively partitions  into the cytosolic fraction whereas  if 
linked to a mitochondrial presequence, it is targeted to the 
mitochondrial matrix (Hurt et al.,  1985).  The fusion pro- 
tein consisting of the entire dihydrofolate reductase coding 
sequence (187 residues),  a  short spacer sequence (7 resi- 
dues), and the NSP1 carboxy-terminal domain from residues 
606-823  (Fig.  1) was expressed in yeast under the control 
of the  alcohol  dehydrogenase promoter.  Expression  was 
demonstrated by immunoblotting using affinity-purified  anti- 
bodies against  mouse DHFR or an immune serum made 
against yeast NSP1 (Fig. 2, lane 3, left and right). A fusion 
protein of ~53 kD on SDS-polyacrylamide gels was seen on 
the immunoblot; the predicted molecular mass according to 
the amino acid sequence was calculated to be 47 kD. Thus, 
the fusion protein migrates slightly abnormal on SDS-poly- 
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acrylamide gels. No band at the position of  the fusion protein 
was seen in a control yeast strain (Fig. 2, lane 2). The fusion 
protein reacted with both the anti-DHFR and anti-NSP1  anti- 
bodies.  The  immunoreaction with anti-DHFR  antibodies 
was highly specific for the DHFR-C-NSP1  fusion protein 
giving only one protein band on the immunoblot with no ap- 
parent proteolytic breakdown (Fig. 2, lane 3, anti-DHFR). 
Thus, the DHFR-C-NSP1 fusion protein is stably expressed 
in yeast. In contrast, the authentic NSP1 protein is suscepti- 
ble to proteolysis even in living cells (see also, Fig. 3 B and 
Hurt, 1988).  The observed proteolytic sensitivity of authen- 
tic NSPI is mainly due to the presence of repetitive sequences 
within the central NSP1 domain. If  the DHFR-C-NSP1 is ex- 
pressed  in  E.  coli,  the  fusion protein  is  proteolytically 
cleaved to a significant extent and a breakdown product cor- 
responding roughly in size to the DHFR moiety becomes 
evident (Fig. 2, lane 4). 
The Fusion Protein Between Dihydrofolate 
Reductase and the NSP1 Carboxy-Terminal Domain 
Can Complement the Nonviable Yeast Mutant 
Lacking a Functional NSP1 Gene 
We wanted to test whether the DHFR-C-NSP1  fusion pro- 
tein, likewise the NSP1 carboxy-terminal domain alone, can 
complement a yeast mutant lacking a functional NSP1 gene. 
In the case of complementation we would argue that this do- 
main folds and acts independently from the rest of the NSP1 
protein. The gene coding for the fusion protein was therefore 
placed under the control of the constitutively active yeast al- 
cohol dehydrogenase promoter, inserted into a 2# plasmid 
Hurt Nuclear  Envelope  Targeting of a  Cytosolic Protein  2833 Figure 5. The DHFR-C-NSP1 
fusion  protein  cofractionates 
with  nuclei.  Expression  of 
DHFR-C-NSPI and authentic 
DHFR in yeast and subcellu- 
lar fractionation  was performed 
as described in Materials and 
Methods. Subcellular fraction- 
ation of a haploid yeast strain 
devoid of authentic NSP1, but 
expressing the DHFR-C-NSPI 
fusion protein (YEP13-AHDI- 
DHFR-C-NSP1 ) and of  a yeast 
strain  expressing  authentic 
DHFR  (pLGSDS-DHFR  ). 
Aliquots of  total cell homoge- 
nate (H), postnuclear  super- 
natant  (PNS),  crude nuclear 
pellet (NP), and fraction I to 
V of a final sucrose gradient 
were  analyzed by SDS-12% 
polyacrylamide  gel  electro- 
phoresis and immunoblotting 
using an immane serum against 
NSPI and NSP2 (EC9-3, top), 
against  the  nuclear  marker 
NOPI  (bottom inset in  top) 
and against  mouse DHFR (low- 
er  panel).  Nuclei,  nuclear 
markers  and  the  DHFR-C- 
NSPI fusion protein were re- 
covered mainly  in the  crude 
nuclear  pellet  (NP)  and  in 
fraction IV of  the final sucrose 
gradient. The positions of the 
fusion  protein,  NSP2,  and 
NOP1,  and  of  authentic 
DHFR  are  indicated  by  ar- 
rows. The molecular  masses 
of a protein standard are also 
shown. 
and transformed into the diploid yeast strain TF2 heterozy- 
gous for NSP1.  Expression of the fusion protein could be 
shown by immunoblotting using antibodies against NSP1 and 
dihydrofolate reductase (Fig. 3 B, lane 1; see also Fig. 2, lane 
3).  This  diploid  transformant  was  sporulated  to  obtain 
haploid  progeny  and  after  tetrad  dissection,  four  viable 
tetrad  spores  could  be  generally  recovered  (Fig.  3  A). 
Haploid progeny from complete tetrads that contained the 
disrupted nspl gene copy and the 2# plasmid with the chi- 
meric gene coding for the DHFR-C-NSP1  fusion protein 
showed no evident growth difference as compared to spores 
with authentic NSP1 (Fig. 3 A). Therefore, complementation 
by the DHFR-C-NSP1 fusion protein was not different from 
control  strains  with  endogenous  NSP1.  Haploid  progeny 
with disrupted nspl transformed with the chimeric gene ex- 
pressed the fusion protein of •53  kD on SDS-polyacryl- 
amide gels, but no NSP1  protein (Fig. 3 B, lanes 2 and 3). 
Again  the  fusion  protein  was  very  stable  in  the  com- 
plemented haploid cells and proteolytic breakdown products 
could not be seen.  This clearly demonstrates that a  full- 
length DHFR-C-NSP1 fusion protein and not a proteolytic 
fragment corresponding to the NSP1  carboxy-terminal do- 
main caused the in vivo complementation of  the yeast mutant 
lacking a  functional NSP1. 
The DHFR-C-NSP1 Fusion Protein Is Located at the 
Nuclear Periphery 
From the complementation studies performed above it was 
concluded that the carboxy-terminal domain of NSP1  can 
target a cytosolic protein to the nuclear periphery and nu- 
clear pores.  To directly demonstrate  this  result,  we  per- 
formed indirect immunofluorescence to determine the exact 
location of the  DHFR-C-NSP1  fusion protein  within  the 
yeast cell using DHFR-specific antibodies (Fig. 4). Affinity- 
purified anti-DHFR antibodies, which on immunoblots re- 
acted only with the fusion protein, but not with NSP1 (see 
also Fig. 2), predominantly stained the nuclear periphery of 
yeast  cells  complemented by  the  NSP1  carboxy-terminal 
moiety of  the chimeric protein (Fig. 4 A). The staining of the 
nuclear boundary was often punctate or patchy, which was 
highly similar to the authentic NSP1  immunolabeling and 
thus typical for nuclear pore labeling in yeast (see also Aris 
and Blobel,  1989; Nehrbass et al., 1990; Davis and Fink, 
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riched in the insoluble nuclear fraction. Subfrac- 
tionation of purified nuclei containing the DHFR- 
C-NSP1 fusion protein was performed essentially 
as described (Ads and Blobel, 1989). Nuclei (50 
ttg) were digested with DNAse/RNAse and cen- 
trifuged to yield a supernatant and pellet. Nuclear 
envelopes were  further treated  with  1%  Triton 
X-100 or 500 mM NaC1 to obtain a supernatant 
and a pellet fraction. Identical equivalents of the 
pellet (P) and supernatant (S) fractions were sepa- 
rated on a SDS-12% polyacrylamide gel and im- 
munoblotted using anti-NSP1/NSP2 (EC9-3; top) 
and NOP1 antibodies (bottom). The positions of 
the DHFR-C-NSP1 fusion protein, NSP2, NOP1, 
and the molecular mass of a protein standard are 
indicated by arrows and lines. 
1990). In contrast, authentic DHFR expressed in yeast was 
found throughout the cell (Fig. 4 B). This confirms the eyto- 
solic location of DHFR which is also indicated by subcellu- 
lar fractionation (see also Fig. 5). In addition, nuclei isolated 
from the yeast strain expressing the DHFR-C-NSP1 fusion 
protein showed a ring- and dot-like staining of the nuclear 
membrane in contrast to  nuclei from a  strain  expressing 
authentic DHFR, which only gave background labeling (Fig. 
4 C). Thus, the punctate and ring-like labeling of  the nuclear 
periphery visualized by indirect immunofluorescence is con- 
sistent with the in vivo complementation studies and directly 
demonstrates that the DHFR-C-NSPI  fusion protein,  like 
authentic NSP1, is localized at the nuclear periphery, most 
likely the nuclear pores. Whether all of the fusion protein is 
located at the nuclear pores or a portion of it can be also as- 
sociated with other nuclear structures can not be decided 
since immuno-EM did not satisfactorily work. However, it 
is not our aim in this paper to give a quantitative estimate 
of the efficiency of nuclear pore association, which in the 
light of an artificial gene fusion approach would be difficult 
to interpret. 
The DHFR-C-NSP1 Fusion Protein Cofractionates 
with Nuclei and the Insoluble Nuclear Fraction 
We were interested to analyze by biochemical means the 
efficiency of nuclear  targeting  and  the  association  of the 
DHFR-C-NSP1  fusion protein  with  nuclear  envelopes in 
the complemented yeast strain. We recently reported a sub- 
cellular fractionation protocol for Saccharomyces cerevisiae 
that  allows  the  efficient and  reliable purification of yeast 
nuclei (Hurt et al.,  1988).  Using this technique,  we per- 
formed a  subcellular (Fig.  5) and subnuclear fractionation 
(Fig. 6) of strains expressing authentic dihydrofolate reduc- 
tase or the DHFR-C-NSP1 fusion protein. Whereas mouse 
DHFR was exclusively found in the postnuclear supernatant 
of yeast cells, but not in the crude nuclear pellet or purified 
nuclei (Fig. 5, bottom), the fusion protein consisting of DHFR 
linked to the NSP1 carboxy-terminal domain cofractionated 
with nuclei and the nuclear markers NOP1 (Fig. 5, top) and 
histone H2B (data not shown). 
After subnuclear fractionation, which allows a distinction 
between loosely bound and tightly associated nuclear pro- 
teins  (Ads  and Blobel,  1989),  the DHFR-C-NSP1  fusion 
protein was not significantly extracted from purified nuclei 
by DNAse,  RNAse,  or detergent,  and  was  only partially 
released by high salt treatment, a condition that completely 
releases the nucleolar protein NOP1 (Fig. 6). Applying the 
same subnuclear fractionation protocol, NSP1 is to a similar 
extent enriched in the salt-resistant nuclear fraction that is 
often referred as to the "pore complex/lamina" preparation 
(data not shown). 
In summary, biochemical data,  indirect immunofluores- 
cence, and in vivo complementation studies demonstrate that 
the biochemical properties, as well as the subcellular and 
subnuclear location of the DHFR-C-NSP1  fusion protein, 
are comparable to those of authentic NSP1.  We therefore 
conclude that the chimeric protein is associated with the nu- 
clear periphery, can be found at the nuclear pores and fulfils 
the same essential function as the endogenous NSP1. 
Discussion 
In this work we have addressed the question of how a protein 
can associate with the nuclear periphery and nuclear pores. 
The targeting of macromolecules to the nuclear pores can 
occur by different mechanisms. Proteins destined for the nu- 
clear interior and initially synthesized in the cytosol carry 
specific nuclear targeting signals that guide them first to the 
nuclear pores and further mediate translocation through the 
nuclear pore complexes (Dingwall and Laskey, 1986; New- 
meyer and Forbes, 1988). It was shown that nuclear proteins 
can bind to components located at the nuclear periphery and 
the nuclear pores (Newmeyer and Forbes,  1988; Akey and 
Goldfarb, 1989) and these nuclear envelope constituents may 
be receptors of the nuclear localization signals. In addition, 
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Figure 7. A heptad repeat model for the NSP1 carboxy-terminal  do- 
main. The amino acid sequence of the NSP1 carboxy-terminal do- 
main from residues 620-823 organized in heptad repeats with op- 
timal alignment of hydrophobic residues at position a and d of the 
repeat a b c d e f g, as compared to the heptad repeats of human 
lamin C from residues 85-203 (McKeon et al., 1986). 
cytosolic factors, which also specifically  bind to nuclear pro- 
teins, have been identified and a role in nuclear transport has 
been suggested (Adam et al., 1989;  Yamasaki et al.,  1989; 
Newmeyer and Forbes, 1990).  However, the mechanism by 
which components of  the nuclear pore complexes or putative 
receptors for nuclear proteins associated with the nuclear 
pores  reach their correct subnuclear location, is still un- 
known.  These questions have not been addressed so far, 
since only a few components of the nuclear pores had been 
identified and little is known about their structure and regu- 
lation. 
We recently identified in yeast an evolutionarily conserved 
and essential nuclear envelope protein, NSP1, which is lo- 
cated at the nuclear pores  (Hurt,  1988;  Nehrbass  et al., 
1990). NSP1 reveals a three domain organization as deduced 
from the primary amino acid sequence and we therefore 
asked which of these domains can mediate the interaction 
with the nuclear pores. By using a gene fusion approach, we 
show  here that the  carboxy-terminal domain of NSPI  is 
sufficient to direct a cytosolic protein, murine DHFR, to the 
nuclear membrane and nuclear pores.  Sequences derived 
from the central repetitive NSP1 domain could not mediate 
a peripheral nuclear location of E. coli B-galactosidase, al- 
though  the  fusion protein  was  found inside  the  nucleus 
(Nehrbass et al.,  1990).  However,  this B-galactosidase fu- 
sion protein may be too bulky (because of tetramerization) 
to become stably assembled into peripheral nuclear struc- 
tures. Therefore, we are currently testing whether a fusion 
protein consisting of repeat sequences from the NSP1 middle 
domain and dihydrofolate reductase is localized at the nu- 
clear periphery and the nuclear pores (Nehrbass, U., unpub- 
lished data). 
What Is the Molecular Basis  for the Association 
of the NSP1 Carboxy-Terminal Domain with the 
Nuclear Pores? 
The entire sequence of the NSP1 earboxy-terminal domain 
is organized into heptad repeats, i.e., a periodic disposition 
of apolar residues at positions a and d within a heptad repeat 
of the form a b c d e f g (Fig. 7). This type of heptad re- 
peat is typically found in intermediate filament proteins such 
as lamins and cytokeratins which can form alpha-helical 
coiled-coils (Steinert and Poop, 1988). Interestingly, the ex- 
istence of yeast lamin A and B analogous has been recently 
suggested  (Georgatos  et  al.,  1989).  Secondary structure 
predictions based on the algorithmic program of Chou and 
Fasman (1978)  suggest that several alpha-helical segments 
occur throughout the entire NSP1 carboxy-terminal domain 
that may be formed through interactions of the hydrophobic 
residues of heptad repeats either with each other or with an- 
other protein containing similar sequence repeats. 
Consistent with this model is that a mutation in one of the 
NSP1 carboxy-terminal heptad repeats (glutamic acid 706 in 
proline;  see also Fig.  7),  which could interfere with the 
alpha-helical organization, results in severe impairment of 
the NSP1 function and temperature-sensitive growth of the 
mutant (Nehrhass et al.,  1990).  In this mutant, NSP1 was 
no longer strictly associated with the nuclear periphery, but 
was also found in numerous aggregates in the cytosol (Nehr- 
bass et al.,  1990). 
Together, these results and those using the gene fusion ap- 
proach suggest that the NSP1 carboxy-terminal domain con- 
tains signals that can specifically bind to component(s) lo- 
cated at the nuclear boundary, presumably the nuclear pores. 
This docking process may depend on alpha-helical interac- 
tions between amphipathic heptad repeats. Whether NSP1 
first dimerizes through its carboxy-terminal domain and then 
binds to a receptor-like component at the nuclear pores, or 
whether the monomeric NSP1 carboxy-terminal directly in- 
teracts with a component of similar heptad repeat organiza- 
tion  and  located at  the  nuclear  pores  requires  further 
clarification. 
It is interesting to note that the carboxy-terminal domain 
of rat liver p62 nucleoporin (D'Onofrio et al., 1988),  a pro- 
tein located at the nuclear pores in higher eucaryotes (Davis 
and Blobel,  1986)  and implied to be involved in nuclear 
transport  (Featherstone et al.,  1988;  Finlay and Forbes, 
1990), shows a distinct homology to the yeast NSP1 carboxy- 
terminal domain (Carmo-Fonseca, M., and E. Hurt, manu- 
script in preparation) as well as a similar heptad repeat orga- 
nization (Start et al.,  1990).  Thus, this type of sequence 
motif may also mediate nuclear pore association in higher 
eucaryotes, and is conserved during evolution from yeast 
to man. 
It is surprising that the carboxy-terminal domain is still 
functional, even when the globular and compactly folded di- 
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argues that authentic NSP1  is  split up into different func- 
tional domains that fold and function independently from 
each other.  We have identified at least one function of the 
carboxy-terminal domain that is involved in nuclear pore as- 
sociation. We will exploit the DHFR characteristics to iden- 
tify putative docking components of NSP1 located at the nu- 
clear pores by affinity ligand purification using methotrexate 
affinity columns.  The function of the second domain,  the 
highly repetitive central part of NSP1, is not known and func- 
tional analysis is more difficult to perform because it is not 
essential for cell growth. Interestingly, NSP1  repetitive se- 
quences  are  also  found in other nuclear proteins  such as 
NUP1  (Davis and Fink,  1990) and NSP2 (Nehrbass et al., 
1990). NUP1 was shown to be localized to the nuclear pores. 
Thus, proteins with this new type of NSPl-like repetitive se- 
quences seem to occur preferentially at the nuclear pores im- 
plying  a  pore-specific  function.  It  remains  to  be  shown 
whether NSP1 and NSPl-like proteins form a complex that 
associates  with the nuclear pores. 
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